TRastuzumab 是人源化单克隆抗体，以高亲和力与HER2选择性结合，可用于 HER2 阳性转移性乳腺癌和 HER2 阳性胃癌的研究。
产品描述
Trastuzumab is a humanized monoclonal antibody for patients with invasive breast cancers that overexpress HER2. Trastuzumab has been clinically used to treat HER2 Positive Metastatic Breast Cancer and HER2 Positive Gastric Cancer.
Cas No.
180288-69-1
分子量
146 kDa
m.cnreagent.com